Literature DB >> 8813788

Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors.

T Holm1, L E Rutqvist, H Johansson, B Cedermark.   

Abstract

Adjuvant preoperative radiotherapy in patients with rectal cancer improves local control and possibly overall survival. However, an increased postoperative mortality rate after radiotherapy has been observed in some trials. This study was based on 1399 patients in two randomized trials of radiotherapy. It reviewed the causes of death after operation and attempted to identify risk factors for postoperative mortality in patients with rectal cancer treated with or without high-dose (5 x 5 Gy) preoperative radiotherapy. The majority of deaths were from cardiovascular disease or infection. The risk of postoperative mortality was significantly increased in patients irradiated with a two-portal technique to a relatively large volume compared with those not given radiotherapy, but not in those irradiated with a four-portal technique to a limited volume. Age, sex, tumour stage and coexistent cardiovascular disease were independent risk factors for postoperative mortality. The risk of postoperative death in patients with rectal cancer is related to the preoperative radiotherapy technique.

Entities:  

Mesh:

Year:  1996        PMID: 8813788     DOI: 10.1002/bjs.1800830725

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  14 in total

Review 1.  [Radiotherapy-associated morbidity and mortality in rectal surgery].

Authors:  Y Kulu; M W Büchler; A Ulrich
Journal:  Chirurg       Date:  2013-11       Impact factor: 0.955

2.  Management of stage II/III rectal cancer.

Authors:  Timothy D Wagner; Marwan G Fakih; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2010-12

3.  Accuracy of transrectal ultrasound after preoperative radiochemotherapy compared to computed tomography and magnetic resonance in locally advanced rectal cancer.

Authors:  Jacopo Martellucci; M Scheiterle; B Lorenzi; F Roviello; F Cetta; E Pinto; G Tanzini
Journal:  Int J Colorectal Dis       Date:  2012-02-03       Impact factor: 2.571

4.  Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications.

Authors:  G Valero; J A Luján; Q Hernández; M De Las Heras; E Pellicer; A Serrano; P Parrilla
Journal:  Int J Colorectal Dis       Date:  2003-07-15       Impact factor: 2.571

5.  Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers.

Authors:  Yon Kuei Lim; Wai Lun Law; Rico Liu; Jensen T C Poon; Joe F M Fan; Oswens S H Lo
Journal:  World J Surg Oncol       Date:  2010-03-26       Impact factor: 2.754

Review 6.  Anastomotic leakage after low anterior resection for rectal cancer: facts, obscurity, and fiction.

Authors:  Panagiotis Taflampas; Manousos Christodoulakis; Dimitrios D Tsiftsis
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

7.  Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database.

Authors:  Y Nancy You; Nancy N Baxter; Andrew Stewart; Heidi Nelson
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

Review 8.  [Indications for neoadjuvant therapy in rectal carcinoma].

Authors:  F Zimmermann; M Molls
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

Review 9.  [Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status].

Authors:  C Rödel; W Hohenberger; R Sauer
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

10.  Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004.

Authors:  Bärbel Jung; Lars Påhlman; Robert Johansson; Erik Nilsson
Journal:  BMC Cancer       Date:  2009-02-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.